About
AAV Immuno-Gene Therapy
Areas of Focus
Categories
Virus TechnologyGene Therapy, RNA & Peptide TherapyBiotech
Team (15)
Akela Kuwahara, PhD
Chief of Staff, Director of Corporate Strategy
Siren Biotechnology
team_member
Beverly Davidson, PhD
Vector Engineering
Siren Biotechnology
team_member
Carolina López, PhD
Viral Genome Immunogenicity
Siren Biotechnology
team_member
Chris Lovejoy, MS
Scientist - Preclinical Research
Siren Biotechnology
team_member
Ed Schnipper, MD
Clinical Lead
Siren Biotechnology
team_member
Justin Lee, BS
Associate Scientist - Preclinical research
Siren Biotechnology
team_member
Clinical Trials (1)
View allTotal Trials
1
As Lead Sponsor
0
As Collaborator
1
Total Enrollment
75
By Phase
NA: 1
By Status
COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
Today
Hover over trial bars to see details
Funding History (1)
D
Apr 22, 2024
Locations (1)
Headquarters
San Francisco, CA, United States
Map
Loading map...